What is Intravene?
Intravene has been a key player in Central Virginia since 1989, specializing in delivering high-quality intravenous care. The company operates a network of facilities across Lynchburg, Danville, Roanoke, and Charlottesville, ensuring accessible infusion therapy services. Their comprehensive offerings include antibiotic, hydration, biologic, osteoporosis, asthma, and IVIG therapies, all administered within their licensed clinical settings. Intravene differentiates itself by providing a more cost-effective alternative to hospital-based treatments, further supported by a dedicated financial assistance team to guide patient choices.
How much funding has Intravene raised?
Intravene has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
What's next for Intravene?
With its large-scale late-stage funding context, Intravene is poised for significant scaling and strategic development. The recent major strategic investment suggests a focus on expanding its operational footprint, enhancing its service portfolio, or potentially integrating new technologies to optimize patient care delivery. This capital infusion will likely enable Intravene to solidify its market leadership in Central Virginia and explore opportunities for broader geographic reach or service diversification, reinforcing its commitment to accessible and cost-effective infusion therapies.
See full Intravene company page
